Outcomes in Patients with Chronic Kidney Disease Referred Late to Nephrologists: A Meta-analysis

American Journal of Medicine

Volumn 120, Issue 12, 2007, Pages

  Chan, Micah R ^a   Dall, Aaron T ^a   Fletcher, Kathlyn E ^b   Lu, Na ^c   Trivedi, Hariprasad ^d  

^a Div of General Internal Medicine   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Graduate School of Biomedical Sciences   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Chronic kidney disease; Dialysis; Hospitalization; Mortality; Referral; Timing

Indexed keywords

CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; HOSPITALIZATION; HUMAN; INTERNET; LANGUAGE; LENGTH OF STAY; MORTALITY; NEPHROLOGIST; PATIENT REFERRAL; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; SCISEARCH;

HUMANS; KIDNEY FAILURE, CHRONIC; LENGTH OF STAY; NEPHROLOGY; PUBLICATION BIAS; REFERRAL AND CONSULTATION; RENAL REPLACEMENT THERAPY; TIME FACTORS;

EID: 36448979949     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.04.024     Document Type: Review

References (46)

1. United States Renal Data System. 2006 Annual Data Report (2006), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. http://www.usrds.org Available at: http://www.usrds.org. Accessed October 11, 2006.
2. United States Renal Data System. 2000 Annual Data Report (2000), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. http://www.usrds.org Availble at: http://www.usrds.org. Accessed October 11, 2006.
3. Xue J.L., Ma J.Z., Louis T.A., and Collins A.J. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 12 (2001) 2753-2758
4. Eadington D.W. Delayed referral for dialysis. Nephrol Dial Transplant 11 (1996) 2124-2126
5. Huisman R.M. The deadly risk of late referral. Nephrol Dial Transplant 19 (2004) 2175-2180
6. Cooper H., and Hedges L.V. The Handbook of Research Synthesis (1994), Russell Sage Foundation, New York, NY
7. Sutton A.J., Abrams K., Jones D.R., et al. Methods for Meta-analysis in Medical Research (2000), John Wiley and Sons, Somerset, NJ
8. Campbell J.D., Ewigman B., Hosokawa M., and Van Stone J.C. The timing of referral of patients with end-stage renal disease. Dial Transplant 18 (1989) 660-686
9. Chesser A.M., and Baker L.R. Temporary vascular access for first dialysis is common, undesirable and usually avoidable. Clin Nephrol 1 (1999) 228-232
10. Dogan E., Erkoc R., Sayarlioglu H., et al. Effects of late referral to a nephrologist in patients with chronic renal failure. Nephrology 10 (2005) 516-519
11. Ellis P.A., Reddy V., Bari N., and Cairns H.S. Late referral of end-stage renal failure. QJM 91 (1998) 727-732
12. Fan S.L., Marsh F.P., Raftery M.J., and Yaqoob M.M. Do patients referred late for peritoneal dialysis do badly?. Perit Dial Int 22 (2002) 630-632
13. Goncalves E.A., Andreoli M.C., Watanabe R., et al. Effect of temporary catheter and late referral on hospitalization and mortality during the first year of hemodialysis treatment. Artif Organs 28 (2004) 1043-1049
14. Goransson L.G., and Bergrem H. Consequences of late referral of patients with end-stage renal disease. J Intern Med 250 (2001) 154-159
15. Jungers P., Massy Z.A., Nguyen-Khoa T., et al. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant 16 (2001) 2357-2364
16. Kessler M., Frimat L., Panescu V., and Briancon S. Impact of nephrology referral on early and midterm outcomes in ESRD: Epidemiologie de l'insuffisance REnale chronique terminale en lorraine (EPIREL): Results of a 2-year, prospective, community-based study. Am J Kidney Dis 42 (2003) 474-485
17. Kinchen K.S., Sadler J., Fink N., et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 137 (2002) 479-486
18. Lhotta K., Zoebl M., Mayer G., and Kronenberg F. Late referral defined by renal function: association with morbidity and mortality. J Nephrol 16 (2003) 855-861
19. Lin C.L., Wu M.S., Hsu P.Y., and Huang C.C. Improvement of clinical outcome by early nephrology referral in type II diabetics on hemodialysis. Ren Fail 25 (2003) 455-464
20. Ratcliffe P.J., Phillips R.E., and Oliver D.O. Late referral for maintenance dialysis. Br Med J (Clin Res Ed) 288 (1984) 441-443
21. Ravani P., Marinangeli G., Stacchiotti L., and Malberti F. Structured pre-dialysis programs: more than just timely referral?. J Nephrol 16 (2003) 862-869
22. Roderick P., Jones C., Tomson C., and Mason J. Late referral for dialysis: improving the management of chronic renal disease. QJM 95 (2002) 363-370
23. Roderick P., Jones C., Drey N., et al. Late referral for end-stage renal disease: a region-wide survey in the south west of England. Nephrol Dial Transplant 17 (2002) 1252-1259
24. Roubicek C., Brunet P., Huiart L., et al. Timing of nephrology referral: influence on mortality and morbidity. Am J Kidney Dis 36 (2000) 35-41
25. Schmidt R.J., Domico J.R., Sorkin M.I., and Hobbs G. Early referral and its impact on emergent first dialyses, health care costs, and outcome. Am J Kidney Dis 32 (1998) 278-283
26. Stack A.G. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis 41 (2003) 310-318
27. Stoves J., Bartlett C.N., and Newstead C.G. Specialist follow up of patients before end stage renal failure and its relationship to survival on dialysis. Postgrad Med J 77 (2001) 586-588
28. Van Biesen W., Wiedemann M., and Lameire N. End-stage renal disease treatment: a European perspective. J Am Soc Nephrol 9 Suppl 12 (1998) S55-S62
29. Winkelmayer W.C., Owen Jr. W.F., Levin R., and Avorn J. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 14 2 (2003) 486-492
30. Szklo M., and Nieto J. Epidemiology: Beyond the Basics (2000), Aspen Publishers, Inc, Gaithersburg, MD
31. Harris R.P., Helfand M., Woolf S.H., et al., Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20 Suppl 3 (2001) 21-35
32. Fletcher K.E., Underwood W., Davis S.Q., et al. Effects of work hour reduction of residents' lives. A systematic review. JAMA 294 (2005) 1088-1100
33. National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 Suppl 2 (2002) S1-S266
34. Wauters J.P., Lameire N., Davison A., and Ritz E. Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement. Nephrol Dial Transplant 20 (2005) 490-496
35. Mendelssohn D.C., Barrett B.J., Brownscombe L.M., et al. Elevated levels of serum creatinine: recommendations for management and referral. CMAJ 161 (1999) 413-417
36. Consensus Development Conference Panel. Morbidity and mortality of renal dialysis: an NIH consensus conference statement. Ann Intern Med 121 (1994) 62-70
37. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. [published correction appears in Ann Intern Med. 2003;139:605]. Ann Intern Med 139 (2003) 137-147
38. Fogarty D.G., Maxwell A.P., Savage G., et al. There is no population level benefit in using estimated glomerular filtration rate (eGFR) versus serum creatinine for identifying and referring patients with CKD. [Abstract]. J Am Soc Nephrol 61 (2005) 319A
39. Van Biesen W., Vanholder R., Veys N., et al. The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes. Nephrol Dial Transplant 21 (2006) 77-83
40. Suki W.N. Are physician assistants the answer to a shortage of nephrologists?. Am J Kidney Dis 33 (1999) 796-797
41. Dwyer J.T., Larive B., Leung J., et al. Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study?. Kidney Int 68 (2005) 1766-1776
42. Revicki D.A., Brown R.E., Feeny D.H., et al. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 25 (1995) 548-554
43. Xue J.L., St. Peter W.L., Ebben J.P., et al. Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis 40 (2002) 1153-1161
44. Martinez-Ramirez H.R., Jalomo-Martinez B., Cortes-Sanabria L., et al. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist. Am J Kidney Dis 47 1 (2006) 78-87
45. Egger M., Smith G.D., and Phillips A.N. Meta-analysis: principles and procedures. BMJ 315 (1997) 1533-1537
46. Higgins JPT, Green S. Analysing and presenting results. Cochrane Handbook for Systematic Reviews of Interventions. 4.2.5 [updated May 2005]. Available at: http://www.cochrane.org/resources/handbook/hbook.htm. Accessed December 8, 2006.